WELCOME MESSAGE:
Thrombosis-2015 is the global forum devoted to the topic of: "Thrombosis: advances in clinical diagnosis and therapeutic interventions". I would encourage researchers, decision makers in hematology, physicians, pharmaceutical industry and healthcare representatives around the globe to participate in this event and to exchange scientific knowledge and recent achievements in this important area.
Thrombosis-2015 aims to promote the international exchange of ideas as well as to enlarge collaborative research network among academia and industry.
Young scientists, postdoctoral researchers, graduate students and other professionals are cordially invited to the Workshop entitled "NIH Research Resources in Thrombosis". Numerous research and clinical topics in Thrombosis and Hemostasis are suggested for presentations.
I believe that the Thrombosis-2015 will be professionally fruitful and will provide unforgettable experience for all the attendees and look forward to seeing you all at the ancient and very beautiful city of Beijing.
With warm regards,
Sincerely,
Sincerely,
Sergey ZaetsMD
Novo Nordisk, Inc
USA
USA
ABOUT CONFERENCE:
OMICS GroupConferences takes immense pleasure & feel honored in inviting the contributors across the globe to “International Conference on Thrombosis and Hemostasis (Thrombosis- 2015)” to be held during November 2-4, 2015 at Beijing, China. Thrombosis-2015 will focus the latest and exciting innovations in allied areas of Hematology and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions. The theme of conference “Advances in clinical diagnosis and therapeutic interventions” reflects the emerging progress being made in Blood related disorders and advances in diagnosis as discoveries in the lab are translated into useful technologies in an increasingly targeted and precise manner. OMICS International Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open Access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
The Important of conference is to update, clinically relevant audience regarding the evidence supporting current Advances in diagnosis of Thrombosis and Hemostasis, Researchers and scientists whole over the world can exchange ideas and views. Students from different universities gather together and improve their knowledge; Pharmaceutical companies can exhibit their new products and research and development methods. In China more than 250 Universities/ colleges, 165 pharmaceutical companies, and more than 50 Associations and societies are working on Thrombosis and hemostasis and other blood related disorders. Funding grants by the government of china for research nearly 9 million USD$ to universities and 5 million USD$ to the pharmaceutical and research institutes.
For more information, please visit: Thrombosis Market Analysis
CONFERENCE HIGHLIGHTS:
Special Issues:
- All accepted abstracts will be published in respective OMICS Group Journals
- Abstracts will be provided with Digital Object Identifier by Cross Ref.